Literature DB >> 15372753

Diagnosis and staging of pancreatic tumors.

Silvana C Faria1, Eric P Tamm, Evelyne M Loyer, Janio Szklaruk, Haesun Choi, Chusilp Charnsangavej.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15372753     DOI： 10.1016/j.ro.2004.06.012

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN： 0037-198X            Impact factor:   0.800


× No keyword cloud information.
  6 in total

Review 1.  Beyond the whipple operation: radical resections for cancers of the head of the pancreas.

Authors:  Hans F Schoellhammer; Bryan S Goldner; Joseph Kim; Gagandeep Singh
Journal:  Indian J Surg Oncol       Date:  2013-07-17

2.  Preoperative therapies for resectable and borderline resectable pancreatic cancer.

Authors:  Gauri R Varadhachary
Journal:  J Gastrointest Oncol       Date:  2011-09

3.  Borderline resectable pancreatic cancer.

Authors:  Gauri R Varadhachary; Eric P Tamm; Christopher Crane; Douglas B Evans; Robert A Wolff
Journal:  Curr Treat Options Gastroenterol       Date:  2005-10

Review 4.  Therapeutic options for the management of pancreatic cancer.

Authors:  Maria L Rossi; Azeem A Rehman; Christopher S Gondi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.

Authors:  X-X Li; N-B Liu; L Zhu; X-K Yuan; C-W Yang; P Ren; L-L Gong; L-J Zhao; W-G Xu; P Wang
Journal:  Br J Radiol       Date:  2015-05-05       Impact factor: 3.039

6.  Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer.

Authors:  Sho Yasuta; Tatsushi Kobayashi; Hidetoshi Aizawa; Shinichiro Takahashi; Masafumi Ikeda; Masaru Konishi; Motohiro Kojima; Hirofumi Kuno; Katsuhiko Uesaka; Soichiro Morinaga; Atsushi Miyamoto; Hirochika Toyama; Norihisa Takakura; Keishi Sugimachi; Wataru Takayama
Journal:  BMC Cancer       Date:  2020-12-02       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.